Cargando…
Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and has been considered a very immunogenic tumor. The treatment with radiofrequency ablation (RFA) has been established as the standard ablative therapy for early HCC, and is currently recognized as the main ablative tool for HCC...
Autores principales: | da Costa, Adriano Carneiro, Sodergren, Mikael, Jayant, Kumar, Santa Cruz, Fernando, Spalding, Duncan, Pai, Madhava, Habib, Nagy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267689/ https://www.ncbi.nlm.nih.gov/pubmed/32536773 http://dx.doi.org/10.3748/wjg.v26.i17.2040 |
Ejemplares similares
-
Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma
por: Kumar, Jayant, et al.
Publicado: (2018) -
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022) -
Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer
por: Mazmishvili, Ketevan, et al.
Publicado: (2018) -
Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma
por: Huang, Kai Wen, et al.
Publicado: (2019) -
COVID-19 and gut immunomodulation
por: Roy, Koushik, et al.
Publicado: (2021)